Victory Capital Management Inc. trimmed its stake in Humana Inc. (NYSE:HUM – Get Rating) by 3.2% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 253,055 shares of the insurance provider’s stock after selling 8,492 shares during the period. Victory Capital Management Inc. owned about 0.20% of Humana worth $110,646,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds have also bought and sold shares of HUM. Mitsubishi UFJ Kokusai Asset Management Co. Ltd. grew its holdings in Humana by 15.2% during the 4th quarter. Mitsubishi UFJ Kokusai Asset Management Co. Ltd. now owns 61,164 shares of the insurance provider’s stock worth $28,469,000 after acquiring an additional 8,066 shares during the period. Riverview Trust Co acquired a new stake in Humana during the 1st quarter worth about $32,000. Transcend Capital Advisors LLC grew its holdings in Humana by 18.3% during the 1st quarter. Transcend Capital Advisors LLC now owns 587 shares of the insurance provider’s stock worth $255,000 after acquiring an additional 91 shares during the period. CWM LLC acquired a new stake in Humana during the 4th quarter worth about $218,000. Finally, LPL Financial LLC grew its holdings in Humana by 5.9% during the 4th quarter. LPL Financial LLC now owns 18,367 shares of the insurance provider’s stock worth $8,520,000 after acquiring an additional 1,024 shares during the period. 94.93% of the stock is currently owned by institutional investors and hedge funds.
Humana Price Performance
Humana stock opened at $478.35 on Thursday. Humana Inc. has a 52 week low of $351.20 and a 52 week high of $497.47. The company’s 50 day moving average price is $460.24 and its two-hundred day moving average price is $438.81. The company has a quick ratio of 1.53, a current ratio of 1.53 and a debt-to-equity ratio of 0.74. The stock has a market cap of $60.51 billion, a P/E ratio of 20.29, a P/E/G ratio of 1.42 and a beta of 0.80.
Analyst Upgrades and Downgrades
A number of analysts have weighed in on HUM shares. Credit Suisse Group set a $548.00 price target on Humana in a report on Tuesday, July 19th. StockNews.com upgraded Humana from a “buy” rating to a “strong-buy” rating in a research note on Wednesday, April 20th. Sanford C. Bernstein initiated coverage on Humana in a research note on Thursday, May 26th. They issued a “market perform” rating and a $506.00 target price for the company. Wells Fargo & Company raised their target price on Humana from $512.00 to $514.00 and gave the company an “overweight” rating in a research note on Wednesday, May 25th. Finally, Truist Financial raised their target price on Humana from $490.00 to $550.00 and gave the company a “hold” rating in a research note on Thursday, July 14th. Five research analysts have rated the stock with a hold rating, twelve have assigned a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $499.61.
Insiders Place Their Bets
In other Humana news, insider Samir Deshpande sold 3,957 shares of Humana stock in a transaction that occurred on Tuesday, May 3rd. The shares were sold at an average price of $434.19, for a total transaction of $1,718,089.83. Following the transaction, the insider now owns 5,529 shares of the company’s stock, valued at approximately $2,400,636.51. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Insiders own 0.39% of the company’s stock.
Humana Inc, together with its subsidiaries, operates as a health and well-being company in the United States. It operates through three segments: Retail, Group and Specialty, and Healthcare Services. The company offers medical and supplemental benefit plans to individuals. It also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.
- Get a free copy of the StockNews.com research report on Humana (HUM)
- The MarketBeat Podcast: Portfolio Management in Market Downturns
- Can These Two Airline Stocks Overcome Gravity And Fly Higher?
- Shopify Stock Rallies Despite Quarterly Loss
- Two Automation Stocks The Institutions Are Buying
- Can Owens-Corning Insulate Your Portfolio?
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.